158 related articles for article (PubMed ID: 30511498)
1. Results of the combined U.S. multicenter postapproval study of the Nit-Occlud PDA device for percutaneous closure of patent ductus arteriosus.
Kobayashi D; Salem MM; Forbes TJ; Gordon BM; Soriano BD; Dimas V; Goldstein BH; Owada C; Javois A; Bass J; Jones TK; Berman DP; Gillespie MJ; Moore JW; Levi DS
Catheter Cardiovasc Interv; 2019 Mar; 93(4):645-651. PubMed ID: 30511498
[TBL] [Abstract][Full Text] [Related]
2. Results of the combined U.S. Multicenter Pivotal Study and the Continuing Access Study of the Nit-Occlud PDA device for percutaneous closure of patent ductus arteriosus.
Moore JW; Greene J; Palomares S; Javois A; Owada CY; Cheatham JP; Hoyer MH; Jones TK; Levi DS;
JACC Cardiovasc Interv; 2014 Dec; 7(12):1430-6. PubMed ID: 25523534
[TBL] [Abstract][Full Text] [Related]
3. Multicenter nit-occlud® PDA-R patent. Ductus arteriosus occlusion device trial: initial and six-month results.
Granja MA; Trentacoste L; Rivarola M; Barbosa JD; Lucini V; Peirone A; Spillman A
Catheter Cardiovasc Interv; 2015 Aug; 86(2):258-63. PubMed ID: 23460494
[TBL] [Abstract][Full Text] [Related]
4. Trans-catheter closure of patent ductus arteriosus-What is the best device?
Ghasemi A; Pandya S; Reddy SV; Turner DR; Du W; Navabi MA; Mirzaaghayan MR; Kiani A; Sloan K; Forbes TJ
Catheter Cardiovasc Interv; 2010 Nov; 76(5):687-95. PubMed ID: 20815044
[TBL] [Abstract][Full Text] [Related]
5. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
Boudjemline Y
Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter closure of large patent ductus arteriosus at high altitude with a novel nitinol device.
Heath A; Lang N; Levi DS; Granja M; Villanueva J; Navarro J; Echazú G; Kozlik-Feldmann R; del Nido P; Freudenthal F
Catheter Cardiovasc Interv; 2012 Feb; 79(3):399-407. PubMed ID: 21805617
[TBL] [Abstract][Full Text] [Related]
7. Immediate angiographic residual shunt using the Nit-Occlud device for patent ductus arteriosus closure.
Hiremath G; Aggarwal V; Soule K; Bass JL
Postepy Kardiol Interwencyjnej; 2020 Dec; 16(4):460-465. PubMed ID: 33598020
[TBL] [Abstract][Full Text] [Related]
8. Implantation of the new Nit-Occlud PDA-R device in children below 10 kilogram.
Moysich A; Happel CM; Laser KT; Kececioglu D; Haas NA
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1203-8. PubMed ID: 25258039
[TBL] [Abstract][Full Text] [Related]
9. Results of the phase I food and drug administration clinical trial of duct-occlud device occlusion of patent ductus arteriosus.
Moore JW; DiMeglio D; Javois AP; Takahashi M; Berdjis F; Cheatham JP
Catheter Cardiovasc Interv; 2001 Jan; 52(1):74-8. PubMed ID: 11146528
[TBL] [Abstract][Full Text] [Related]
10. Results of coil closure of patent ductus arteriosus using a tapered tip catheter for enhanced control.
Devanagondi R; Latson L; Bradley-Skelton S; Prieto L
Catheter Cardiovasc Interv; 2016 Aug; 88(2):233-8. PubMed ID: 26800854
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of patent ductus arteriosus using the AMPLATZER™ duct occluder II (ADO II).
Gruenstein DH; Ebeid M; Radtke W; Moore P; Holzer R; Justino H
Catheter Cardiovasc Interv; 2017 May; 89(6):1118-1128. PubMed ID: 28258658
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta.
Masri S; El Rassi I; Arabi M; Tabbakh A; Bitar F
Catheter Cardiovasc Interv; 2015 Aug; 86(2):E66-72. PubMed ID: 26032159
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of patent ductus arteriosus with the Nit-Occlud
Maksymenko AV; Kuzmenko YL; Dovhaliuk AA; Motrechko OO; Herrmann FE; Haas NA; Lehner A
Ann Pediatr Cardiol; 2019; 12(3):206-211. PubMed ID: 31516276
[TBL] [Abstract][Full Text] [Related]
14. Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience.
El-Said HG; Bratincsak A; Foerster SR; Murphy JJ; Vincent J; Holzer R; Porras D; Moore J; Bergersen L
J Am Heart Assoc; 2013 Nov; 2(6):e000424. PubMed ID: 24284214
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous closure of the patent ductus arteriosus using the Nit-Occlud PDA-R (reverse) device: initial experience reporting immediate and short-term results.
Peirone A; Diaz J; Contreras A; Banille E; Cabrera M; Spillmann A; Bueno N; Juaneda E
J Invasive Cardiol; 2011 Dec; 23(12):513-6. PubMed ID: 22147399
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Bilici M; Demir F; Akın A; Türe M; Balık H; Kuyumcu M
Pediatr Cardiol; 2017 Dec; 38(8):1598-1605. PubMed ID: 28828684
[TBL] [Abstract][Full Text] [Related]
17. [Patent ductus arteriosus closure using a new device: the Nit-Occlud device].
Gamboa R; Mollón FP; Ríos-Méndez RE; Arroyo GM; Fogel A; Villa DM
Rev Esp Cardiol; 2007 Apr; 60(4):445-8. PubMed ID: 17521554
[TBL] [Abstract][Full Text] [Related]
18. Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams.
Sathanandam SK; Gutfinger D; O'Brien L; Forbes TJ; Gillespie MJ; Berman DP; Armstrong AK; Shahanavaz S; Jones TK; Morray BH; Rockefeller TA; Justino H; Nykanen DG; Zahn EM
Catheter Cardiovasc Interv; 2020 Nov; 96(6):1266-1276. PubMed ID: 32433821
[TBL] [Abstract][Full Text] [Related]
19. Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study.
Sungur M; Karakurt C; Ozbarlas N; Baspinar O
Catheter Cardiovasc Interv; 2013 Aug; 82(2):245-52. PubMed ID: 23460349
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils.
Celiker A; Aypar E; Karagöz T; Dilber E; Ceviz N
Catheter Cardiovasc Interv; 2005 Aug; 65(4):569-76. PubMed ID: 15973674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
